Cholinesterase inhibitors and memantine in more advanced Alzheimer’s disease: the debate continues

By Dwolatzky Tzvi   Clarfield A Mark  

Aging Health, Vol. 8, Iss. 3, 2012-06 ,pp. : 233-237

Future Medicine

Access to resources Recommend Favorite

Glaucoma and Alzheimer’’s disease in the elderly

By Bizrah Mukhtar   Guo Li   Cordeiro Maria Francesca  

Aging Health, Vol. 7, Iss. 5, 2011-10 ,pp. : 719-733

Future Medicine

Access to resources Recommend Favorite

Memantine in the treatment of Alzheimer’s disease

By Porsteinsson Anton P   Cosman Kelly M  

Aging Health, Vol. 2, Iss. 6, 2006-12 ,pp. : 891-904

Future Medicine

Access to resources Recommend Favorite

Early detection of Alzheimer’s disease

By Seltzer Ben  

Aging Health, Vol. 3, Iss. 4, 2007-08 ,pp. : 449-456

Future Medicine

Access to resources Recommend Favorite

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model

By Hyde Christopher   Peters Jaime   Bond Mary   Rogers Gabriel   Hoyle Martin   Anderson Rob   Jeffreys Mike   Davis Sarah   Thokala Praveen   Moxham Tiffany  

Age and Ageing, Vol. 42, Iss. 1, 2013-01 ,pp. : 14-20

Oxford University Press

Access to resources Recommend Favorite